Loading
  • Pipeline Pipeline
    • Pipeline Chart
    • Validive
      • Overview
      • Severe Oral Mucositis and Oropharyngeal Cancer
      • Phase 2 Data Supports Further Development in OPC
      • MNPR-301-001 Clinical Trial
    • Camsirubicin
      • Overview
      • Clinical Data
      • Development Strategy
      • MNPR-201-001 Clinical Trial
    • MNPR-101 RIT & MNPR-101-Zr
    • MNPR-101
      • Overview
      • Development Strategy
    • MNPR-202
    • Collaborations
      • Overview
      • Current Collaborations
    • Intellectual Property
    • Publications
      • Validive
      • Camsirubicin
      • MNPR-101
  • Investors Investors
    • Overview
    • Annual Meeting
    • News / Events
      • Press Releases
      • IR Calendar
      • In the News
      • Email Alerts
    • Company Information
      • Profile
      • Presentations
      • Our Team
      • FAQ
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Corporate Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Our Team Our Team
  • Contact Us Contact Us
  • SIV Materials SIV Materials
  • Home
  • Investors
  • News / Events
  • In the News
Investors

Investors

  • Overview
  • Annual Meeting
  • News / Events
    • Press Releases
    • IR Calendar
    • In the News
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Our Team
    • FAQ
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Press Releases
  • IR Calendar
  • In the News
  • Email Alerts

In the News

Scholars Join Forces on Anti-Cancer Drug

Scholars Join Forces on Anti-Cancer Drug

Sep 21, 2022

Monopar Therapeutics readies two key clinical trials in fourth quarter

Oct 6, 2020
Monopar Therapeutics Rings the Opening Bell

Monopar Therapeutics Rings the Opening Bell

Mar 11, 2020
Best first-day IPO

Best first-day IPO

Feb 12, 2020
Double success for Chandler Robinson

Double success for Chandler Robinson

Feb 4, 2020
Article Published by Northwestern University on January 28, 2020

Article Published by Northwestern University on January 28, 2020

Jan 28, 2020
RSS
  • About
  • Pipeline
  • Investors
  • Our Team
  • Contact Us
  • SIV Materials
  • Pipeline
  • Pipeline Chart
  • Validive
  • Camsirubicin
  • MNPR-101 RIT & MNPR-101-Zr
  • MNPR-101
  • MNPR-202
  • Collaborations
  • Intellectual Property
  • Publications
  • Investors
  • Overview
  • Annual Meeting
  • News / Events
  • Company Information
  • Stock Data
  • SEC Filings
  • Corporate Governance

Terms and Conditions of Use

© 2023 Monopar Therapeutics Inc. All Rights Reserved.